1. Home
  2. IDAI vs ICU Comparison

IDAI vs ICU Comparison

Compare IDAI & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo T Stamp Inc.

IDAI

T Stamp Inc.

HOLD

Current Price

$2.72

Market Cap

15.9M

Sector

Technology

ML Signal

HOLD

Logo SeaStar Medical Holding Corporation

ICU

SeaStar Medical Holding Corporation

HOLD

Current Price

$2.47

Market Cap

15.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IDAI
ICU
Founded
2016
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.9M
15.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
IDAI
ICU
Price
$2.72
$2.47
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
34.3K
★ 201.3K
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 76.50
N/A
EPS
N/A
★ N/A
Revenue
N/A
★ $1,234,000.00
Revenue This Year
$59.48
$62.07
Revenue Next Year
$199.81
$46.55
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 814.07
52 Week Low
$1.17
$0.22
52 Week High
$5.28
$5.38

Technical Indicators

Market Signals
Indicator
IDAI
ICU
Relative Strength Index (RSI) 42.29 37.13
Support Level $2.31 $2.33
Resistance Level $2.80 $2.82
Average True Range (ATR) 0.25 0.41
MACD -0.05 -0.10
Stochastic Oscillator 15.38 3.27

Price Performance

Historical Comparison
IDAI
ICU

About IDAI T Stamp Inc.

T Stamp Inc develops and markets identity authentication software solutions for enterprise partners and peer-to-peer markets. The company is engaged in developing proprietary artificial intelligence-powered solutions; researching and leveraging biometric science, cryptography, and data mining to deliver insightful identity & trust predictions while identifying and defending against fraudulent identity attacks, protecting sensitive user information, and extending the reach of digital services through accessibility. The company operates in one reportable segment, artificial intelligence-powered solutions. The artificial intelligence-powered solutions segment generates revenue from software licenses, professional services, and recurring SaaS revenue.

About ICU SeaStar Medical Holding Corporation

SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.

Share on Social Networks: